{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:56:01Z","timestamp":1790621761404,"version":"4.1.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sexual Medicine Reviews"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.sxmr.2017.07.005","type":"journal-article","created":{"date-parts":[[2017,9,2]],"date-time":"2017-09-02T13:30:49Z","timestamp":1504359049000},"page":"529-535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Collagenase Clostridium histolyticum in the Treatment of Peyronie's Disease\u2014A Review of the Literature and a New Modified Protocol"],"prefix":"10.1093","volume":"5","author":[{"given":"Amr","family":"Abdel Raheem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Abdel-Raheem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Capece","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ralph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1016\/j.sxmr.2017.07.005_bib1","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/sj.ijir.3900877","article-title":"Clinical presentations of Peyronie's disease","volume":"14","author":"Pryor","year":"2002","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.sxmr.2017.07.005_bib2","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1464-410X.2006.05969.x","article-title":"Risk factors for Peyronie's disease: a case control study","volume":"97","author":"Bjekic","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.sxmr.2017.07.005_bib3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.sxmr.2015.10.002","article-title":"The genetic basis of Peyronie's disease: a review","volume":"4","author":"Herati","year":"2016","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.sxmr.2017.07.005_bib4","first-page":"2359","article-title":"The medical management of Peyronie's disease: evidence-based 2010 guidelines","volume":"7","author":"Ralph","year":"2010","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2017.07.005_bib5","first-page":"3446","article-title":"Penile duplex ultrasonography in men with Peyronie's disease: is it veno-occlusive dysfunction or poor cavernosal arterial inflow that contributes to erectile dysfunction?","volume":"8","author":"Chung","year":"2011","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2017.07.005_bib6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1464-4096.2001.02436.x","article-title":"A\u00a0retrospective review of 307 men with Peyronie's disease; results of a large survey","volume":"88","author":"Kadioglu","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.sxmr.2017.07.005_bib7","first-page":"1376","article-title":"The natural history of Peyronie's disease","volume":"144","author":"Gelbard","year":"1990","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2017.07.005_bib8","first-page":"2115","article-title":"An analysis of the natural history of Peyronie's disease","volume":"175","author":"Mulhall","year":"2006","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2017.07.005_bib9","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/0092623X.2014.985351","article-title":"The impact of Peyronie's disease on the patient: gaps in our current understanding","volume":"42","author":"Goldstein","year":"2016","journal-title":"J\u00a0Sex Marital Ther"},{"key":"10.1016\/j.sxmr.2017.07.005_bib10","first-page":"1985","article-title":"The chronology of depression and distress in men with Peyronie's disease","volume":"5","author":"Nelson","year":"2008","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2017.07.005_bib11","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/andr.12058","article-title":"Therapeutic advances in the treatment of Peyronie's disease","volume":"3","author":"Yafi","year":"2015","journal-title":"Andrology"},{"key":"10.1016\/j.sxmr.2017.07.005_bib12","first-page":"903","article-title":"Is there a place for conservative treatment in Peyronie's disease?","volume":"6","author":"Vardi","year":"2009","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2017.07.005_bib13","first-page":"1167","article-title":"A\u00a0survey of primary care physicians and urologists regarding Peyronie's disease","volume":"4","author":"LaRochelle","year":"2007","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2017.07.005_bib14","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.eururo.2006.10.042","article-title":"Systematic evidence-based analysis of plaque injection therapy for Peyronie's disease","volume":"51","author":"Russell","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.sxmr.2017.07.005_bib15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.eururo.2006.10.048","article-title":"Seeking answers on the quest for effective nonsurgical treatment of Peyronie's disease","volume":"51","author":"Levine","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.sxmr.2017.07.005_bib16","first-page":"1527","article-title":"Peyronie's disease (CME)","volume":"4","author":"Bella","year":"2007","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2017.07.005_bib17","first-page":"6","article-title":"Summary of the recommendations on sexual dysfunctions in men","volume":"1","author":"Lue","year":"2004","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2017.07.005_bib18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00042307-200411000-00015","article-title":"Critical analysis of surgery for Peyronie's disease","volume":"14","author":"Kendirci","year":"2004","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.sxmr.2017.07.005_bib19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5534\/wjmh.2016.34.2.65","article-title":"Nonsurgical interventions for Peyronie's disease: update as of 2016","volume":"34","author":"Joice","year":"2016","journal-title":"World J Mens Health"},{"key":"10.1016\/j.sxmr.2017.07.005_bib20","author":"European Medicines Agency"},{"key":"10.1016\/j.sxmr.2017.07.005_bib21","author":"Auxilium Pharmaceuticals"},{"key":"10.1016\/j.sxmr.2017.07.005_bib22","first-page":"641","article-title":"Humoral immune responses in Peyronie's disease patients receiving clostridial collagenase therapy","volume":"135","author":"Hamilton","year":"1986","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2017.07.005_bib23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00255956","article-title":"Collagenase for Peyronie's disease experimental studies","volume":"10","author":"Gelbard","year":"1982","journal-title":"Urol Res"},{"key":"10.1016\/j.sxmr.2017.07.005_bib24","first-page":"280","article-title":"The use of collagenase in the treatment of Peyronie's disease","volume":"134","author":"Gelbard","year":"1985","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2017.07.005_bib25","first-page":"56","article-title":"Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study","volume":"149","author":"Gelbard","year":"1993","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2017.07.005_bib26","first-page":"2268","article-title":"Phase 2b study of the clinical efficacy and safety of collagenase Clostridium histolyticum in patients with Peyronie's disease","volume":"187","author":"Gelbard","year":"2012","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2017.07.005_bib27","first-page":"199","article-title":"Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of Peyronie's disease in 2 large double-blind, randomized, placebo controlled phase 3 studies","volume":"190","author":"Gelbard","year":"2013","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2017.07.005_bib28","first-page":"2822","article-title":"Baseline characteristics from an ongoing phase 3 study of collagenase clostridium histolyticum in patients with Peyronie's disease","volume":"10","author":"Gelbard","year":"2013","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2017.07.005_bib29","first-page":"248","article-title":"Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study","volume":"12","author":"Levine","year":"2015","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2017.07.005_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/bju.13932","article-title":"Safety and effectiveness of collagenase clostridium histolyticum (CCH) (Xiapex\u00ae) in the treatment of Peyronie's disease using a new modified shortened protocol","author":"Abdel Raheem","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.sxmr.2017.07.005_bib31","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1464-410X.2010.09365.x","article-title":"The role of vacuum pump therapy to mechanically straighten the penis in Peyronie's disease","volume":"106","author":"Abdel Raheem","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.sxmr.2017.07.005_bib32","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.eururo.2013.10.026","article-title":"Words of wisdom. Safety and tolerability of collagenase Clostridium histolyticum for the treatment of Peyronie's disease in 2 large double-blind, randomized, placebo controlled phase 3 studies","volume":"65","author":"Abdel Raheem","year":"2014","journal-title":"Eur Urol"}],"container-title":["Sexual Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052117300756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052117300756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T14:36:49Z","timestamp":1672756609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2050052117300756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S2050052117300756"],"URL":"https:\/\/doi.org\/10.1016\/j.sxmr.2017.07.005","relation":{},"ISSN":["2050-0521"],"issn-type":[{"value":"2050-0521","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Collagenase Clostridium histolyticum in the Treatment of Peyronie's Disease\u2014A Review of the Literature and a New Modified Protocol","name":"articletitle","label":"Article Title"},{"value":"Sexual Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sxmr.2017.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}